Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes

OBJECTIVE: The incretins glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) account for up to 60% of postprandial insulin release in healthy people. Previous studies showed a reduced incretin effect in patients with type 2 diabetes but a robust response to exogeno...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Salehi, Marzieh, Aulinger, Benedict, Prigeon, Ronald L., D'Alessio, David A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Diabetes Association 2010
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2874693/
https://ncbi.nlm.nih.gov/pubmed/20215429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db09-1253
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi